Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiri Shulman

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Inflammatory Bowel Diseases|October 15, 2025
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort StudyHenit Yanai, Tomer Achler, Amir Ben-Tov, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 1, 2025
Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sampleYuval Kozlov, Noa Geffen, Shiri Shulman, et al.
Acta Ophthalmologica|March 1, 2019
Aminobisphosphonate-associated orbital and ocular inflammatory diseaseShay Keren, Igal Leibovitch, Ran Ben Cnaan, et al.
Biomedicines|January 8, 2025
Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous ChorioretinopathyDavid Rabinovitch, Shiri Shulman, Dafna Goldenberg, et al.
Retina (Philadelphia, Pa.)|November 10, 2009
Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndromeRita Ehrlich, Thomas A Ciulla, Raj Maturi, et al.
BMC Ophthalmology|June 10, 2022
Evaluation of a self-imaging SD-OCT system designed for remote home monitoringJudy E Kim, Oren Tomkins-Netzer, Michael J Elman, et al.
Acta Ophthalmologica|June 28, 2017
Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective studyRoy Schwartz, Zohar Habot-Wilner, Michael R Martinez, et al.
Eye (London, England)|May 1, 2020
A 12-month prospective study to evaluate the efficacy of using the treat-and-extend regimen with intravitreal aflibercept as a Second-Line Treatment for Diabetic Macular Oedema (the TADI Study)Liran Tiosano, Rita Ehrlich, Yoreh Barak, et al.
The British Journal of Ophthalmology|September 3, 2025
Topical β-blockers for treatment of glaucoma and the risk of Parkinson's diseaseAmit Meshi, Nir Giladi, Alon Zahavi, et al.
European Journal of Ophthalmology|June 20, 2018
Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study)Rita Ehrlich, Russell Pokroy, Ori Segal, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Inflammatory Bowel Diseases|October 15, 2025
Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort StudyHenit Yanai, Tomer Achler, Amir Ben-Tov, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 1, 2025
Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sampleYuval Kozlov, Noa Geffen, Shiri Shulman, et al.
Acta Ophthalmologica|March 1, 2019
Aminobisphosphonate-associated orbital and ocular inflammatory diseaseShay Keren, Igal Leibovitch, Ran Ben Cnaan, et al.
Biomedicines|January 8, 2025
Choroidal Response to Intravitreal Bevacizumab Injections in Treatment-Naïve Macular Neovascularization Secondary to Chronic Central Serous ChorioretinopathyDavid Rabinovitch, Shiri Shulman, Dafna Goldenberg, et al.
Retina (Philadelphia, Pa.)|November 10, 2009
Intravitreal bevacizumab for choroidal neovascularization secondary to presumed ocular histoplasmosis syndromeRita Ehrlich, Thomas A Ciulla, Raj Maturi, et al.
BMC Ophthalmology|June 10, 2022
Evaluation of a self-imaging SD-OCT system designed for remote home monitoringJudy E Kim, Oren Tomkins-Netzer, Michael J Elman, et al.
Acta Ophthalmologica|June 28, 2017
Eplerenone for chronic central serous chorioretinopathy-a randomized controlled prospective studyRoy Schwartz, Zohar Habot-Wilner, Michael R Martinez, et al.
Eye (London, England)|May 1, 2020
A 12-month prospective study to evaluate the efficacy of using the treat-and-extend regimen with intravitreal aflibercept as a Second-Line Treatment for Diabetic Macular Oedema (the TADI Study)Liran Tiosano, Rita Ehrlich, Yoreh Barak, et al.
The British Journal of Ophthalmology|September 3, 2025
Topical β-blockers for treatment of glaucoma and the risk of Parkinson's diseaseAmit Meshi, Nir Giladi, Alon Zahavi, et al.
European Journal of Ophthalmology|June 20, 2018
Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study)Rita Ehrlich, Russell Pokroy, Ori Segal, et al.
Pageof 5